We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Oridis Licenses Tissue Microarray Technology

By Labmedica staff writers
Posted on 05 Dec 2006
Oridis Biomed (Graz, Austria), a biopharmaceutical company, announced that it has entered into a license agreement with the National Institutes of Health (NIH, Bethesda, MD, USA) for the worldwide commercial use of NIH's proprietary tissue microarray (TMA).

TMAs are a tool within Oridis Biomed's Tissomics platform, which permits the rapid and simultaneous study of several hundred tissue samples, using standardized high-throughput analysis by in-house pathologists.

"We are pleased to have been granted by the NIH a license for this TMA technology”, said Georg Casari, Ph.D., head of Oridis Biomed's Tissomics business. More...
"This license agreement further strengthens our Tissomics business for the life-science industry worldwide, where we offer our clients the ability to validate their research, such as biomarker and target verification programs.”

Oridis Biomed commercializes its proprietary Tissomics platform in collaboration with industrial partners, as well as its own research and development programs. The company is developing diagnostics, biomarkers (targeted treatment solutions), and therapeutics for liver diseases. Therapeutic programs include primary liver cancer (hepatocellular carcinoma, HCC) and metabolic liver diseases, such as alcoholic steatohepatitis (ASH) and non- alcoholic steatohepatitis (NASH), where incidence rates are rapidly increasing, while treatment options are limited, expensive, and often ineffective.



Related Links:
Oridis Biomed
National Institutes of Health

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.